John Stevens

Heartport, Inc. develops systems and procedures for heart surgery. The company's technologies allow surgeons to perform a wide range of less invasive open-chest and minimally invasive heart operations, including stopped heart and beating heart procedures. Heartport was founded in 1991 and is headquartered in Redwood City, CA.

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA.

AMP Capital Partners LLC is a venture capital firm, founded in 2000, located in Palo Alto, California.

Enel Geothermal LLC develops geothermal power technology solutions. It regenerates usable energy from industrial waste heat. The company was founded in 2002 and is headquartered in Draper, UT.

Sundrop Fuels, Inc. provides technology to produce any type of renewable, liquid advanced biofuel, from gasoline to diesel and aviation fuels. Its high-temperature solar gasification process turns plant material into liquid transportation fuel for immediate use in automobiles, diesel engines and aircraft. The company was founded by Jensen Reed and P. Michael Masterson in 2008 and is headquartered in Longmont, CO.

Headwaters Capital Partners seeks investment opportunities in lower middle market companies located in the US and Canada. The fund focuses on sectors such as heating ventilation air conditioning & refrigeration, freight rail, delivery, maritime, logistics, transportation, trucking & warehousing. It invests in both control and non-control situations & often invests alongside management or existing sponsors or investors. It provides financing in the form equity and debt for growth capital requirements with an investment size ranging from $10 - $30 million.

Clene Nanomedicine, Inc. is a clinical-stage biopharmaceutical company, which develops therapeutic candidates for neurodegenerative diseases. It focuses on the development of therapeutic nanocatalyst, CNM-Au8, for treatment of neurodegenerative diseases with a Phase 3 study underway in amyotrophic lateral sclerosis (ALS), and concurrent Phase 2 clinical programs ongoing for the neuroreparative treatment of multiple sclerosis, Parkinson's disease, and ALS. The company was founded by Reed N. Wilcox and Mark G. Mortenson in 2013 and and is headquartered in Salt Lake City, UT.